Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jesper Brok

Showing results (51-60 of 76) with videos related to

Pageof 8
Sort By:
Nature Reviews. Disease Primers|October 15, 2021
Wilms tumourFilippo Spreafico, Conrad V Fernandez, Jesper Brok, et al.
Pediatric Blood & Cancer|January 10, 2023
Advances in the clinical management of high-risk Wilms tumorsMichael V Ortiz, Christa Koenig, Amy E Armstrong, et al.
Pediatric Blood & Cancer|April 25, 2023
Advances in the clinical management of high-risk Wilms tumorsMichael V Ortiz, Christa Koenig, Amy E Armstrong, et al.
Pediatric Nephrology (Berlin, Germany)|October 5, 2021
Long-term kidney function in children with Wilms tumour and constitutional WT1 pathogenic variantMaria Pia Falcone, Kathryn Pritchard-Jones, Jesper Brok, et al.
Journal of Pediatric Surgery|September 27, 2021
Surgical management, staging, and outcomes of Wilms tumours with intravascular extension: Results of the IMPORT studyKristina Dzhuma, Mark Powis, Gordan Vujanic, et al.
Pediatric Blood & Cancer|August 9, 2024
Multimodality detection of tumour rupture in children with Wilms tumourKristina Dzhuma, Minou Oostveen, Tom Watson, et al.
European Journal of Cancer (Oxford, England : 1990)|December 20, 2020
Unmet needs for relapsed or refractory Wilms tumour: Mapping the molecular features, exploring organoids and designing early phase trials - A collaborative SIOP-RTSG, COG and ITCC session at the first SIOPE meetingJesper Brok, Annelies M C Mavinkurve-Groothuis, Jarno Drost, et al.
Pediatric Blood & Cancer|October 28, 2017
Irinotecan for relapsed Wilms tumor in pediatric patients: SIOP experience and review of the literature-A report from the SIOP Renal Tumor Study GroupJanna A Hol, Marry M van den Heuvel-Eibrink, Norbert Graf, et al.
The Lancet. Oncology|July 2, 2018
Relapse of Wilms' tumour and detection methods: a retrospective analysis of the 2001 Renal Tumour Study Group-International Society of Paediatric Oncology Wilms' tumour protocol databaseJesper Brok, Marta Lopez-Yurda, Harm V Tinteren, et al.
Frontiers in Pediatrics|April 1, 2022
A Phase II Trial of a Personalized, Dose-Intense Administration Schedule of <sup>177</sup>Lutetium-DOTATATE in Children With Primary Refractory or Relapsed High-Risk Neuroblastoma-LuDO-NFredrik Sundquist, Kleopatra Georgantzi, Kirsten Brunsvig Jarvis, et al.
Pageof 8

Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
Nature Reviews. Disease Primers|October 15, 2021
Wilms tumourFilippo Spreafico, Conrad V Fernandez, Jesper Brok, et al.
Pediatric Blood & Cancer|January 10, 2023
Advances in the clinical management of high-risk Wilms tumorsMichael V Ortiz, Christa Koenig, Amy E Armstrong, et al.
Pediatric Blood & Cancer|April 25, 2023
Advances in the clinical management of high-risk Wilms tumorsMichael V Ortiz, Christa Koenig, Amy E Armstrong, et al.
Pediatric Nephrology (Berlin, Germany)|October 5, 2021
Long-term kidney function in children with Wilms tumour and constitutional WT1 pathogenic variantMaria Pia Falcone, Kathryn Pritchard-Jones, Jesper Brok, et al.
Journal of Pediatric Surgery|September 27, 2021
Surgical management, staging, and outcomes of Wilms tumours with intravascular extension: Results of the IMPORT studyKristina Dzhuma, Mark Powis, Gordan Vujanic, et al.
Pediatric Blood & Cancer|August 9, 2024
Multimodality detection of tumour rupture in children with Wilms tumourKristina Dzhuma, Minou Oostveen, Tom Watson, et al.
European Journal of Cancer (Oxford, England : 1990)|December 20, 2020
Unmet needs for relapsed or refractory Wilms tumour: Mapping the molecular features, exploring organoids and designing early phase trials - A collaborative SIOP-RTSG, COG and ITCC session at the first SIOPE meetingJesper Brok, Annelies M C Mavinkurve-Groothuis, Jarno Drost, et al.
Pediatric Blood & Cancer|October 28, 2017
Irinotecan for relapsed Wilms tumor in pediatric patients: SIOP experience and review of the literature-A report from the SIOP Renal Tumor Study GroupJanna A Hol, Marry M van den Heuvel-Eibrink, Norbert Graf, et al.
The Lancet. Oncology|July 2, 2018
Relapse of Wilms' tumour and detection methods: a retrospective analysis of the 2001 Renal Tumour Study Group-International Society of Paediatric Oncology Wilms' tumour protocol databaseJesper Brok, Marta Lopez-Yurda, Harm V Tinteren, et al.
Frontiers in Pediatrics|April 1, 2022
A Phase II Trial of a Personalized, Dose-Intense Administration Schedule of <sup>177</sup>Lutetium-DOTATATE in Children With Primary Refractory or Relapsed High-Risk Neuroblastoma-LuDO-NFredrik Sundquist, Kleopatra Georgantzi, Kirsten Brunsvig Jarvis, et al.
Pageof 8